interleukin-4 and 13 concentrations in infants at risk to develop bronchopulmonary dysplasiainterleukin-4浓度和13在婴儿的风险开发支气管肺的发育不良.pdfVIP

下载本文档

1
0
约5.05万字
约 8页
2017-09-11 发布于上海
举报
版权申诉

interleukin-4 and 13 concentrations in infants at risk to develop bronchopulmonary dysplasiainterleukin-4浓度和13在婴儿的风险开发支气管肺的发育不良.pdf

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

interleukin-4 and 13 concentrations in infants at risk to develop bronchopulmonary dysplasiainterleukin-4浓度和13在婴儿的风险开发支气管肺的发育不良

BMC Pediatrics BioMed Central Research article Open Access Interleukin-4 and 13 concentrations in infants at risk to develop Bronchopulmonary Dysplasia 1 2 1 R John Baier* , John Loggins and Thomas E Kruger Address: 1Department of Pediatrics Louisiana State University Health Sciences Center 1501 Kings Highway Shreveport, Louisiana 71130-3932, USA and 2Louisiana State University Health Sciences Center 1501 Kings Highway, Shreveport, Louisiana 71130-3932, USA Email: R John Baier* - jbaier@; John Loggins - jloggi@; Thomas E Kruger - dkruger1@ * Corresponding author Published: 18 August 2003 Received: 28 March 2003 Accepted: 18 August 2003 BMC Pediatrics 2003, 3:8 This article is available from: /1471-2431/3/8 © 2003 Baier et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the articles original URL. Abstract Background: An exaggerated inflammatory response occurs in the first few days of life in infants who subsequently develop bronchopulmonary dysplasia (BPD). The increase of inflammatory cytokines in many disease processes is generally balanced by a rise in anti-inflammatory cytokines. Interleukin-4 (IL-4) and interleukin-13 (IL-13) have been shown to inhibit production of several inflammatory cytokines important in the development of BPD.